`
` AO 120 (Rev. 08/10)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`for the Northern District of West Virginia
`filed in the U.S. District Court
`on the following
`G Trademarks or G Patents. ( G the patent action involves 35 U.S.C. § 292.):
`DOCKET NO.
`DATE FILED
`U.S. DISTRICT COURT
`:23-CV-89
`11/8/2023
`for the Northern District of West Virginia
`PLAINTIFF
`DEFENDANT
`REGENERON PHARMACEUTICALS, INC.
`CELLTRION, INC.
`
`✔ 1
`
`PATENT OR
`TRADEMARK NO.
`See attached
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
`DATE INCLUDED
`
`PATENT OR
`TRADEMARK NO.
`
`In the above—entitled case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`G Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`G Other Pleading
`G Cross Bill
`G Answer
`HOLDER OF PATENT OR TRADEMARK
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
`In the above—entitled case, the following decision has been rendered or judgement issued:
`DECISION/JUDGEMENT
`
`CLERK
`CHERYL DEAN RILEY
`
`(BY) DEPUTY CLERK
`D. Kinsey
`
`DATE
`
`11/9/2023
`
`Copy 1—Upon initiation of action, mail this copy to Director Copy 3—Upon termination of action, mail this copy to Director
`Copy 2—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`
`
`Case 1:23-cv-00089-TSK Document 3 Filed 11/09/23 Page 2 of 3 PageID #: 3402
`
`PATENT OR
`TRADEMARK NO.
`7,070,959
`9,222,106
`9,254,338
`9,315,281
`9,816,110
`10,130,681
`10,415,055
`10,464,992
`10,669,594
`10,828,345
`10,888,601
`10,927,342
`11,053,280
`11,066,458
`11,084,865
`11,104,715
`11,174,283
`11,253,572
`11,299,532
`11,306,135
`11,312,936
`11,332,771
`11,459,374
`11,472,861
`11,485,770
`11,505,593
`
`DATE OF PATENT OR
`TRADEMARK
`July 4, 2006
`December 29, 2015
`February 9, 2016
`April 19, 2016
`November 14, 2017
`November 20, 2018
`September 17, 2019
`November 5, 2019
`June 2, 2020
`November 10, 2020
`January 12, 2021
`February 23, 2021
`July 6, 2021
`July 20, 2021
`August 10, 2021
`August 31, 2021
`November 16, 2021
`February 22, 2022
`April 12, 2022
`April 19, 2022
`April 26, 2022
`May 17, 2022
`October 4, 2022
`October 18, 2022
`November 1, 2022
`November 22, 2022
`
`HOLDER OF PATENT OR
`TRADEMARK
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`
`
`
`Case 1:23-cv-00089-TSK Document 3 Filed 11/09/23 Page 3 of 3 PageID #: 3403
`
`11,525,833
`11,535,663
`11,542,317
`11,548,932
`11,555,176
`11,559,564
`11,707,506
`11,732,024
`11,753,459
`11,769,597
`11,788,102
`11,793,926
`
`December 13, 2022
`December 27, 2022
`January 3, 2023
`January 10, 2023
`January 17, 2023
`January 24, 2023
`July 25, 2023
`August 22, 2023
`September 12, 2023
`September 26, 2023
`October 17, 2023
`October 24, 2023
`
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`Regeneron Pharmaceuticals, Inc.
`
`
`
`
`
`2
`
`